Rising Prevalence of Age-Related Macular Degeneration Fuels Growth in Global AMD Market 2022 - 2030

Age-Related Macular Degeneration (AMD) is a medical condition that affects the central portion of the retina, causing vision loss and visual distortions. It is a leading cause of blindness in the elderly population and is characterized by the progressive degeneration of the macula. The Age-Related Macular Degeneration (AMD) market is expected to grow significantly in the coming years, driven by factors such as the aging population, increasing incidence of AMD, and advancements in diagnostic and treatment techniques. The market offers significant opportunities for growth, with the increasing demand for minimally invasive surgical procedures and the growing popularity of telemedicine. The market players must address the challenges faced by the market, including the high cost of treatment and limited access to healthcare services, to ensure sustainable growth in the long term.

Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1355

The global age-related macular degeneration (AMD) market was valued at US$ 9.84 Bn in 2021, growing at an estimated CAGR of 7% over the forecast period. The scope of the AMD market covers various diagnostic techniques, including fundus photography, optical coherence tomography (OCT), and fluorescein angiography. The market also covers various treatment options, including medications, surgical procedures, and vision rehabilitation.

Some of the Key Players Operating in the Global Age-Related Macular Degeneration (AMD) Market include:
AbbVie Inc.
Apellis Pharmaceuticals
Bausch Health Companies Inc.
Bayer AG
Hoffman-La Roche Ltd.
Novartis AG
Opthea
Outlook Therapeutics Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.

Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1355

Market Dynamics:

Drivers: The aging population, increasing incidence of AMD, and advancements in diagnostic and treatment techniques are the primary drivers of the AMD market.

Restraints: The high cost of treatment, limited access to healthcare services, and a lack of awareness among patients are the main restraints of the AMD market.

Opportunities: The increasing demand for minimally invasive surgical procedures, the growing popularity of telemedicine, and the increasing adoption of regenerative medicine offer significant opportunities for the AMD market.

Challenges: The lack of standardization in diagnostic and treatment techniques, the limited availability of skilled professionals, and the need for continuous monitoring are the major challenges faced by the AMD market.

Reasons to Buy this Report:
Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment.
The analysis acknowledges that the sector players & key drivers of both conflicts and growth assess the impact of limitations as well as the opportunities on the sector.
Data regarding the industry share by every item fragment, alongside their reasonable worth, have been served in the report.
We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players. This will help the company to increase its efficiency.
Our report helps readers decipher the current and future constraints of the market and optimal business strategies to enhance market development.

Purchase the latest in-depth Global Age-Related Macular Degeneration (AMD) Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1355

Global Age-Related Macular Degeneration (AMD) Market Segmentation:

By Type
Wet AMD
Dry AMD

By Diagnosis
Visual acuity test
Pupil dilation
Fluorescein angiography
Amsler grid
Indocyanine green angiography
Optical coherence tomography (OCT)
Optical coherence tomography angiography (OCTA)
Others

By Treatment
Anti-vascular endothelial growth factor (anti-VEGF) drugs
Photodynamic therapy
Photocoagulation
Others

By Stages
Early AMD
Intermediate AMD
Advanced AMD

By Age Group
Less than 60
Between 60 to 80
More than 80

By Region
North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1355

We appreciate your reading the article in its entirety. If you would like to know more about the Age-Related Macular Degeneration (AMD) market, looking for customization, contact us. To achieve a full market reach of Age-Related Macular Degeneration (AMD), or explore more about opportunities reach our research analyst. Our team is available 24/7 to assist and support our customers through reliable research.

Access the full report here: https://www.absolutemarketsinsights.com/reports/Global-Age-Related-Macular-Degeneration-AMD-Market-2022-2030-1355

Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com

About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

This release was published on openPR.